Rigel Pharmaceuticals, Inc. (RIGL)

NASDAQ: RIGL · Real-Time Price · USD

Compare

34.94

+0.32 (0.92%)

At close: Feb 11, 2026, 4:00 PM EST

34.34

-0.60 (-1.72%)

After-hours: Feb 11, 2026, 6:20 PM EST

Rigel Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	282.08	179.28	115.78	115.74	138.74	108.62
Other Revenue	-	-	0.1	-	-	-
Revenue	282.08	179.28	115.88	115.74	138.74	108.62
Revenue Growth (YoY)	79.13%	54.71%	0.12%	-16.57%	27.73%	83.21%
Cost of Revenue	47.7	42.03	31.63	62.02	66.32	61
Gross Profit	234.38	137.25	84.25	53.72	72.42	47.63
Selling, General & Admin	115.43	113.06	105.74	112.45	91.89	76.6
Operating Expenses	115.43	113.06	105.74	112.45	91.89	76.6
Operating Income	118.95	24.19	-21.49	-58.73	-19.48	-28.97
Interest Expense	-7.58	-7.92	-6.87	-3.71	-4.86	-1.35
Interest & Investment Income	2.96	2.09	2.27	0.68	0.05	0.58
EBT Excluding Unusual Items	114.34	18.37	-26.09	-61.75	-24.29	-29.74
Merger & Restructuring Charges	-	-	-	-1.32	-3.52	-
Other Unusual Items	-	-	1	4.5	10.5	-
Pretax Income	114.34	18.37	-25.09	-58.57	-17.31	-29.74
Income Tax Expense	1.04	0.88	-	-	0.61	-
Net Income	113.3	17.49	-25.09	-58.57	-17.91	-29.74
Net Income to Common	113.3	17.49	-25.09	-58.57	-17.91	-29.74
Shares Outstanding (Basic)	18	18	17	17	17	17
Shares Outstanding (Diluted)	18	18	17	17	17	17
Shares Change (YoY)	4.06%	1.64%	2.07%	-0.00%	1.03%	0.81%
EPS (Basic)	6.35	0.99	-1.44	-3.44	-1.05	-1.76
EPS (Diluted)	6.20	0.99	-1.44	-3.44	-1.05	-1.76
Free Cash Flow	68.14	31.44	-5.74	-74.21	5.25	-53.45
Free Cash Flow Per Share	3.73	1.78	-0.33	-4.35	0.31	-3.17
Gross Margin	83.09%	76.56%	72.70%	46.41%	52.20%	43.84%
Operating Margin	42.17%	13.49%	-18.55%	-50.74%	-14.04%	-26.67%
Profit Margin	40.17%	9.75%	-21.65%	-50.61%	-12.91%	-27.38%
Free Cash Flow Margin	24.16%	17.53%	-4.96%	-64.11%	3.79%	-49.20%
EBITDA	121.37	26.42	-20.25	-57.73	-18.31	-28.27
EBITDA Margin	43.03%	14.74%	-17.48%	-49.88%	-13.20%	-26.02%
D&A For EBITDA	2.42	2.23	1.24	1	1.16	0.71
EBIT	118.95	24.19	-21.49	-58.73	-19.48	-28.97
EBIT Margin	42.17%	13.49%	-18.55%	-50.74%	-14.04%	-26.67%
Effective Tax Rate	0.91%	4.80%	-	-	-	-
Revenue as Reported	282.08	179.28	116.88	120.24	149.24	108.62

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q